CC-Chemokine RANTES is increased in serum and urine in the early post-transplantation period of human renal allograft recipients

Kidney and Blood Pressure Research

Volumn 28, Issue 1, 2005, Pages 48-54

  Baer, Patrick C ^a   Koziolek, Michael ^b   Fierlbeck, Wolfgang ^a   Geiger, Helmut ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

RANTES; Renal allograft; Transplantation

Indexed keywords

BETA CHEMOKINE; BIOLOGICAL MARKER; RANTES;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECIPIENT; UPREGULATION; URINALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL5; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RANTES; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 11244354796     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081774     Document Type: Article

References (29)

1. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplant 1993;55:752-757.
2. Song E, Zou H, Yao Y, Proudfoot A, Antus B, Liu S, Jens L, Heemann U: Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002;61:676-685.
3. Pattison J, Nelson PJ, Huie P, Sibley RK, Krensky AM: RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994;343:209-211.
4. Robertson H, Wheeler J, Morley AR, Booth TA, Talbot D, Kirby JA: Beta-chemokine expression and distribution in paraffin-embedded transplant renal biopsie sections: Analysis by scanning laser confocal microscopy. Histochem Cell Biol 1998;110:207-213.
5. Deckers JGM, van der Woude FJ, van der Kooij SW, Daha MR: Synergistic effect of IL-1α, IGN-gamma, and TNF-α on RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998;9:194-202.
6. Baer PC, Scherberich JE, Bereiter-Hahn J, Geiger H: Induction of RANTES, HLA-DR and ICAM-1 by proinflammatory cytokines on highly purified distal tubular cells from human kidney. Transplant 2000;69:2456-2462.
7. Gröne HJ, Weber C, Weber KS, Grone EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlondorff D, Nelson PJ: Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment. FASEB J 1999;13:1371-1383.
8. Mulligan M, McDuffie JE, Shanley TP, Guo RF, Sarma JV, Warner RL, Ward PA: Roles of RANTES in experimental cardiac allograft rejection. Exp Mol Pathol 2000;69:167-174.
9. Van Kooten C, Langers AMJ, Bruijn JA, Daha MR: Role of tubular cells in progressive renal disease. Kidney Blood Pres Res 1999;22:53-61.
10. Boswell RN, Yard BA, Schrama E, van Es LA, Daha MR, van der Woude FJ: Interleukin 6 production by human proximal tubular epithelial cells in vitro: Analysis of effects of interleukin 1 α and other cytokines. Nephrol Dial Transplant 1994;9:599-606.
11. Andersen CB, Blaehr H, Ladefoged S, Larsen S: Expression of the intercellular adhesion molecule-1 (ICAM-1) in human renal allografts and cultured human tubular cells. Nephrol Dial Transplant 1992;7:147-154.
12. Bishop GA, Hall BM, Suranyi MG, Tiller DJ, Horvath JS, Duggin GG: Expression of HLA antigens on renal tubular cells in culture I. Transplant 1986;42:671-678.
13. Frank J, Engler-Blum G, Rodemann HP, Müller GA: Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1993;1:26-35.
14. Fairchild RL, Van Buskirk AM, Kondo T, Wakely ME, Orosz CG: Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplant 1997;63:1807-1812 .
15. Nagano H, Nadeau KC, Takaga M, Kusaka M, Tilney NL: Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplant 1997;63:1101-110 8.
16. Robertson H, Kirby JA: Post-transplant renal tubulitis: The recruitment, differentiation and persistence of intra-epithelial T cells. Am J Transplant 2003;3:3-10.
17. Chandraker A: Diagnostik techniques in the work-up of renal allograft dysfunction - an update. Curr Opin Nephrol Hyperton 1999;8:723-728.
18. Casiraghi F, Ruggenenti P, Noris M, Locatelli G, Perico N, Perna A, Remuzzi G: Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction. Transplant 1997;63:1508-1514.
19. Macchioni P, Boiardi L, Meliconi R, Pulsatelli L, Maldini MC, Ruggeri R, Facchini A, Salvarani C: Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A. J Rheumatol 1998;25:320-325.
20. Kaneko H Ogasawara H, Naito T, Akimoto H, Lee S, Hishikawa T, Sekigawa I, Tokano Y, Takasaki Y, Hirose SI, Hashimoto H: Circulating levels of beta-chemokines in systemic lupus erythematosus. J Rheumatol 1999;26:568-573.
21. Papadaki HA, Eliopoulous GD: Selective loss of peripheral blood CD45RO+ T lymphocytes with increased levels of serum cytokines and endothelial cell-derived soluble cell adhesion molecules in patients with chronic idiopathic neutropenia in adults. Ann Hematol 1998;77:153-159.
22. Pulsatelli L, Meliconi R, Boiardi L, Macchioni P, Salvarani C, Facchini A: Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1998;16:263-268.
23. Malnati MS, Tambussi G, Fischetti L, Algeri M, Veglia F, Capiluppi B, Lazzarin A, Lusso P: Analysis of serum and plasma beta chemokines in primary HIV infections (PHI). J Biol Regul Homeost Agents 2000;14:75-78.
24. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordoy I, Hlfdan A, Kjekshus J, Simonsen S, Froland S, Gullestad L: Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998;97:1136-1143.
25. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G: Interleukin-6 and RANTES in Takayasu arteritis. Circulation 1999;100:55-609.
26. Leone G, Fulgenzi A, Gaja G, Ferrero ME, Corsi MM: RANTES and MCP-1 in renal transplantes patients. Are those two chemokines valid plasma targets in chronic rejection? J Am Soc Nephrol 1999;10:A3723.
27. Sibbring JS, Sharma A, McDicken IW, Sells RA, Christmas SE: Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejection. Tranplant Immun 1998;6:203-208.
28. Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA: Increased urinary excretion of monocytes chemoattractant protein-1 during acute renal allograft rejection. Nephrol Dial Transplant 1996;11:1096-1103.
29. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molnetti EP: Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003;237:660-665.